COMPANY

Nextgenjane Inc.

HQ: Oakland, CA source · nextgenjane.com ↗ · West Coast

NextGen Jane analyzes menstrual blood collected from mailed tampons to study genomic indicators of health and disease. From company website Source · Oct 12, 2026

Keywords: women's health genomics diagnostics research

Location: Oakland, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

3NIH grants

Funding and NIH signals

NIH award NIH awarded $714K (SBIR Phase II 5R44HD118899-02, continuation, notice May 12, 2026). NIH RePORTER 5R44HD118899-02 (May 12, 2026)
Evidence (1 event)
- May 12, 2026 · NIH RePORTER 5R44HD118899-02
  Organization: NEXTGENJANE, INC.; City/State: Oakland, CA; Project number: 5R44HD118899-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-12; FY total cost (award amount): 714095; Administering IC: Eunice Kennedy Shriver National Institute of Child Health and Human Development; Project title: Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

May 12, 2026 Grant Government grant — SBIR: $714,095 (annual award, as published), announced May 12, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Apr 15, 2025 Grant Government grant — SBIR: $759,944 (annual award, as published), announced Apr 15, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

Funding

Last 2 years.

May 12, 2026 Government grant — SBIR: $714,095 (annual award, as published), announced May 12, 2026. Agency: NIH/NICHD. Source: government award database. source ↗
Apr 15, 2025 Government grant — SBIR: $759,944 (annual award, as published), announced Apr 15, 2025. Agency: NIH/NICHD. Source: government award database. source ↗

NIH awards 3

Annual award amounts. Total $1.8M.

Jan 25, 2023 NIH award 5R44HD103159-03 FY2023: $401,530 awarded for that fiscal year; activity R44 (SBIR); PI GIRE, STEPHEN; recipient as written: NEXTGENJANE, INC., Oakland, CA. Developing a non-invasive, definitive diagnostic f source ↗
Feb 8, 2022 NIH award 4R44HD103159-02 FY2022: $1,108,476 awarded for that fiscal year; activity R44 (SBIR); PI GIRE, STEPHEN; recipient as written: NEXTGENJANE, INC., Oakland, CA. Developing a non-invasive, definitive diagnostic source ↗
Aug 21, 2020 NIH award 1R44HD103159-01 FY2020: $267,669 awarded for that fiscal year; activity R44 (SBIR); PI GIRE, STEPHEN; recipient as written: NEXTGENJANE, INC., Oakland, CA. Developing a non-invasive, definitive diagnostic f source ↗